Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.05
39.21
|
Price Target |
|
We'll email you a reminder when the closing price reaches NZD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one FPH stock under the Base Case scenario is 23.36 NZD. Compared to the current market price of 37.76 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Fisher & Paykel Healthcare Corporation Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for FPH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Fisher & Paykel Healthcare Corporation Ltd., a leading provider of innovative medical devices and respiratory products, has carved a prominent niche in the global healthcare market. Founded in New Zealand in 1934, the company has evolved from a humble appliance manufacturer into a key player in respiratory care and sleep medicine. With a mission centered on improving patient outcomes, Fisher & Paykel leverages its strong research and development capabilities to create state-of-the-art products,...
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Fisher & Paykel Healthcare Corporation Ltd
Balance Sheet Decomposition
Fisher & Paykel Healthcare Corporation Ltd
Current Assets | 704.9m |
Cash & Short-Term Investments | 82m |
Receivables | 266.2m |
Other Current Assets | 356.7m |
Non-Current Assets | 1.6B |
PP&E | 1.3B |
Intangibles | 88.4m |
Other Non-Current Assets | 148.4m |
Current Liabilities | 385m |
Accounts Payable | 219.9m |
Other Current Liabilities | 165.1m |
Non-Current Liabilities | 137.6m |
Long-Term Debt | 92.9m |
Other Non-Current Liabilities | 44.7m |
Earnings Waterfall
Fisher & Paykel Healthcare Corporation Ltd
Revenue
|
1.7B
NZD
|
Cost of Revenue
|
-698.4m
NZD
|
Gross Profit
|
1B
NZD
|
Operating Expenses
|
-691m
NZD
|
Operating Income
|
353.4m
NZD
|
Other Expenses
|
-220.8m
NZD
|
Net Income
|
132.6m
NZD
|
Free Cash Flow Analysis
Fisher & Paykel Healthcare Corporation Ltd
NZD | |
Free Cash Flow | NZD |
FPH Profitability Score
Profitability Due Diligence
Fisher & Paykel Healthcare Corporation Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Fisher & Paykel Healthcare Corporation Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
FPH Solvency Score
Solvency Due Diligence
Fisher & Paykel Healthcare Corporation Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Fisher & Paykel Healthcare Corporation Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FPH Price Targets Summary
Fisher & Paykel Healthcare Corporation Ltd
According to Wall Street analysts, the average 1-year price target for FPH is 34.44 NZD with a low forecast of 26.26 NZD and a high forecast of 41.16 NZD.
Dividends
Current shareholder yield for FPH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one FPH stock under the Base Case scenario is 23.36 NZD.
Compared to the current market price of 37.76 NZD, Fisher & Paykel Healthcare Corporation Ltd is Overvalued by 38%.